Prostate Cancer

Raman spectroscopic signatures of prostate cancer progression: correlation with gleason score. July 22, 2026

Optimizing prostate biopsy decision making - (MUSIC-screen): A 1:1 randomized controlled trial comparing micro-ultrasound versus multiparametric magnetic resonance imaging for prostate cancer diagnosis. July 22, 2026

Prostate cancer survivorship in modern times - insights into management of erectile dysfunction and urinary incontinence for clinically localized prostate cancer survivors in the United States. July 22, 2026

Racial Differences in Secondary Treatment Pathways and Survival in Localized Prostate Cancer. July 22, 2026

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis. July 21, 2026

Global research trends and hotspots in robotic-assisted prostate biopsy: a bibliometric analysis from 2008 to 2026. July 21, 2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. July 21, 2026

Structured robotic surgery training in Germany: a five-year evaluation of the German curriculum for robot-assisted radical prostatectomy. July 21, 2026

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer - Beyond the Abstract July 20, 2026

PI-RADS-stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy. July 20, 2026

Evaluation of an Artificial Intelligence Communication Platform for Racial Biases in Pretest Education About Prostate Cancer Germline Testing. July 22, 2026

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial. July 22, 2026

Interference of Clonal Hematopoiesis in cfDNA Liquid Biopsy Testing & Identification of Actionable Alterations in Large Diverse Cohort of US Veterans. July 22, 2026

Imaging Features That Predict Indeterminate Bone Lesion Outcomes on 18F-DCFPyL PSMA PET/CT Scan: A Multicenter Cohort of 42 Biopsy-Proven Lesions - Beyond the Abstract July 21, 2026

CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer. July 21, 2026

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate. July 21, 2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer. July 21, 2026

SBRT plus Abiraterone Acetate and ADT versus Abiraterone Acetate and ADT in Oligometastatic Castrate-Resistant Prostate Cancer (ARTO): Long-Term, Unplanned Overall Survival Analysis of an Open-Label, Randomised, Phase 2 Trial - Beyond the Abstract July 20, 2026

Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer. July 20, 2026

Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology. July 20, 2026

Page 1 of 1645